Brian David Archbold Sells 1,151 Shares of Mesa Laboratories (NASDAQ:MLAB) Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB) SVP Brian David Archbold sold 1,151 shares of the company’s stock in a transaction that occurred on Tuesday, June 16th. The stock was sold at an average price of $101.27, for a total value of $116,561.77. Following the transaction, the senior vice president directly owned 3,710 shares in the company, valued at approximately $375,711.70. This trade represents a 23.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mesa Laboratories Stock Up 0.2%

Shares of NASDAQ:MLAB opened at $95.10 on Friday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.29 and a current ratio of 1.72. Mesa Laboratories, Inc. has a 52-week low of $55.45 and a 52-week high of $113.99. The business’s 50 day simple moving average is $101.92 and its two-hundred day simple moving average is $90.74. The firm has a market cap of $524.95 million, a P/E ratio of 79.25 and a beta of 0.94.

Mesa Laboratories (NASDAQ:MLAB) last released its quarterly earnings data on Wednesday, May 27th. The medical instruments supplier reported $1.53 EPS for the quarter, missing the consensus estimate of $1.78 by ($0.25). Mesa Laboratories had a net margin of 2.69% and a return on equity of 20.96%. The firm had revenue of $63.72 million for the quarter, compared to the consensus estimate of $65.21 million. During the same quarter in the prior year, the firm earned ($1.31) EPS.

Mesa Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Friday, May 29th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Friday, May 29th. Mesa Laboratories’s payout ratio is 53.33%.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings downgraded shares of Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, June 3rd. Two research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Mesa Laboratories has an average rating of “Reduce” and a consensus price target of $94.00.

Institutional Trading of Mesa Laboratories

A number of large investors have recently bought and sold shares of the company. Bank of America Corp DE grew its stake in shares of Mesa Laboratories by 5.9% during the 1st quarter. Bank of America Corp DE now owns 57,871 shares of the medical instruments supplier’s stock worth $5,117,000 after acquiring an additional 3,207 shares during the period. Royal Bank of Canada increased its holdings in Mesa Laboratories by 143.3% in the 1st quarter. Royal Bank of Canada now owns 13,275 shares of the medical instruments supplier’s stock worth $1,173,000 after acquiring an additional 7,818 shares during the last quarter. Quantinno Capital Management LP raised its stake in Mesa Laboratories by 17.9% in the 1st quarter. Quantinno Capital Management LP now owns 4,318 shares of the medical instruments supplier’s stock valued at $382,000 after acquiring an additional 657 shares during the period. Lazard Asset Management LLC bought a new stake in Mesa Laboratories in the 1st quarter valued at about $1,797,000. Finally, Renaissance Technologies LLC lifted its holdings in Mesa Laboratories by 802.9% during the first quarter. Renaissance Technologies LLC now owns 31,600 shares of the medical instruments supplier’s stock valued at $2,794,000 after purchasing an additional 28,100 shares during the last quarter. 90.60% of the stock is owned by hedge funds and other institutional investors.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.